LOXL2 and colorectal carcinoma: In conclusion, the results obtained in our study demonstrated that LOXL2 expression levels may be of clinical significance in CRC, and the mechanisms underlying the effects of this molecule include the activation of FAK/Src signaling and the stabilization of Snail.